NMRA vs TFX · $283.5M cap vs P/E 2083, rev $3.05B
Neumora Therapeutics, Inc. (NMRA) versus Teleflex Incorporated (TFX) — a side-by-side from cached financials, not a winner call.
Neumora Therapeutics, Inc. (NMRA) is a biotechnology company listed on NASDAQ.
Teleflex Incorporated (TFX) is a medical instruments & supplies company listed on NYSE.
NMRA does not have a complete income-statement cache yet.
Latest reported TFX revenue for 2024-12-31 was $3.05B. Net income was $69.7M. Revenue was up 2.4% from 2023-12-31 to 2024-12-31. TFX currently screens at market cap $5.53B and trailing P/E 2082.7.
NMRA currently screens at market cap $283.5M. TFX currently screens at market cap $5.53B and trailing P/E 2082.7.
Not investment advice. Open the NMRA and TFX stock pages for the full models.
Not investment advice.